Medically unexplained and explained physical symptoms in the general population: Association with prevalent and incident mental disorders

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Van Sluijs, Jonna Eck Van Der ^a,b   Have, Margreet Ten ^c   Rijnders, Cees ^d   Van Marwijk, Harm ^e,f   De Graaf, Ron ^c   Van Feltz Cornelis, Christina Der ^a,b,d  

^a TopClinical Centre for Body and Mind   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

^c NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^d Department of Residency Training ^*  (Netherlands)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ALCOHOL ABUSE; ANXIETY DISORDER; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DSM-IV; EDUCATION; EMPLOYMENT STATUS; EXPLAINED PHYSICAL SYMPTOM; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICALLY UNEXPLAINED SYMPTOM; MENTAL DISEASE; NETHERLANDS; PREVALENCE; SUBSTANCE ABUSE; SYMPTOM; SYMPTOMATOLOGY; ADOLESCENT; AFFECT; ANXIETY; CASE CONTROL STUDY; MENTAL DISORDERS; MIDDLE AGED; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AFFECT; ANXIETY; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84928911435     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123274     Document Type: Article

References (63)

1. Arnold IA, de Waal MW, Eekhof JA, Assendelft WJ, Spinhoven P, van Hemert AM. Medically unexplained physical symptoms in primary care: a controlled study on the effectiveness of cognitivebehavioral treatment by the family physician. Psychosomatics. 2009; 50(5):515-24. doi: 10.1176/appi. psy.50.5.515 PMID: 19855038
2. Arnold IA, de Waal MW, Eekhof JA, van Hemert AM. Somatoform disorder in primary care: course and the need for cognitive-behavioral treatment. Psychosomatics. 2006; 47(6):498-503. PMID: 17116951
3. de Waal MW, Arnold IA, Eekhof JA, Assendelft WJ, van Hemert AM. Follow-up study on health care use of patients with somatoform, anxiety and depressive disorders in primary care. BMC Fam Pract. 2008; 9:5. doi: 10.1186/1471-2296-9-5 PMID: 18218070
4. de Waal MW, Arnold IA, Spinhoven P, Eekhof JA, van Hemert AM. The reporting of specific physical symptoms for mental distress in general practice. Journal of psychosomatic research. 2005; 59(2):89-95. PMID: 16186004
5. de Waal MW, Arnold IA, Eekhof JA, van Hemert AM. Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. The British journal of psychiatry: the journal of mental science. 2004; 184:470-6. PMID: 15172939
6. Steinbrecher N, Koerber S, Frieser D, Hiller W. The prevalence of medically unexplained symptoms in primary care. Psychosomatics. 2011; 52(3):263-71. doi: 10.1016/j.psym.2011.01.007 PMID: 21565598
7. Swanson LM, Hamilton JC, Feldman MD. Physician-based estimates of medically unexplained symptoms: a comparison of four case definitions. Fam Pract. 2010; 27(5):7.
8. Kroenke K, Spitzer RL, Williams JB, Linzer M, Hahn SR, deGruy FV 3rd, et al. Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med. 1994; 3(9):774-9. PMID: 7987511
9. Escobar JI, Cook B, Chen CN, Gara MA, Alegria M, Interian A, et al. Whether medically unexplained or not, three or more concurrent somatic symptoms predict psychopathology and service use in community populations. Journal of psychosomatic research. 2010; 69(1):1-8. doi: 10.1016/j.jpsychores.2010. 01.001 PMID: 20630257
10. Allen LA, Gara MA, Escobar JI, Waitzkin H, Silver RC. Somatization: a Debilitating Syndrome in Primary Care. Psychosomatics. 2001; 42(1):63-7. PMID: 11161123
11. Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K. Association of depression and anxiety alone and in combination with chronic musculo-skeletal pain in primary care patients. Psychosomatic medicine. 2008; 70(8):890-7. doi: 10.1097/PSY.0b013e318185c510 PMID: 18799425
12. Hoedeman R, Krol B, Blankenstein N, Koopmans PC, Groothoff JW. Severe MUPS in a sick-listed population: a cross-sectional study on prevalence, recognition, psychiatric co-morbidity and impairment. BMC Public Health. 2009; 9:440. doi: 10.1186/1471-2458-9-440 PMID: 19951415
13. Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosomatic medicine. 2003; 65(4):528-33. PMID: 12883101
14. Hoedeman R, Blankenstein AH, Krol B, Koopmans PC, Groothoff JW. The contribution of high levels of somatic symptom severity to sickness absence duration, disability and discharge. J Occup Rehabil. 2010; 20(2):264-73. doi: 10.1007/s10926-010-9239-3 PMID: 20373134
15. Hoedeman R, Krol B, Blankenstein AH, Koopmans PC, Groothoff JW. Sick-listed employees with severe medically unexplained physical symptoms: burden or routine for the occupational health physician? A cross sectional study. BMC Health Serv Res. 2010; 10:305. doi: 10.1186/1472-6963-10-305 PMID: 21059232
16. Konnopka A, Schaefert R, Heinrich S, Kaufmann C, Luppa M, Herzog W, et al. Economics of medically unexplained symptoms: a systematic review of the literature. Psychotherapy and psychosomatics. 2012; 81(5):265-75. doi: 10.1159/000337349 PMID: 22832397
17. van der Feltz-Cornelis CM, van Oppen P, Ader HJ, van Dyck R. Randomised controlled trial of a collaborative care model with psychiatric consultation for persistent medically unexplained symptoms in general practice. Psychotherapy and psychosomatics. 2006; 75(5):282-9. PMID: 16899964
18. van der Feltz-Cornelis CM, van Balkom AJ. The concept of comorbidity in somatoform disorder-a DSM-V alternative for the DSM-IV classification of somatoform disorder. Journal of psychosomatic research. 2010; 68(1):97-9; author reply 9-100. doi: 10.1016/j.jpsychores.2009.09.011 PMID: 20004307
19. Kroenke K, Jackson JL, Chamberlin J. Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. Am J Med. 1997; 103(5):339-47. PMID: 9375700
20. Simon GE, Vonkorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation between somatic symptoms and depression. N Eng J Med. 1999; 341(18):1329-35. PMID: 10536124
21. Mergl R, Seidscheck I, Allgaier AK, Möller HJ, Hegerl U, Henkel V. Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition. Depress Anxiety. 2007; 24(3):185-95. PMID: 16900465
22. Verhaak PF, Prins MA, Spreeuwenberg P, Draisma S, van Balkom TJ, Bensing JM, et al. Receiving treatment for common mental disorders. General hospital psychiatry. 2009; 31(1):46-55. doi: 10.1016/ j.genhosppsych.2008.09.011 PMID: 19134510
23. Schulberg HC. Treating depression in primary care practice: applications of research findings. J Fam PRACT. 2001; 50(6):535-7. PMID: 11401741
24. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity. Arch Intern Med. 2003; 163(20):2433-45. PMID: 14609780
25. Huijbregts KM, van der Feltz-Cornelis CM, van Marwijk HW, de Jong FJ, van der Windt DA, Beekman AT. Negative association of concomitant physical symptoms with the course of major depressive disorder: a systematic review. Journal of psychosomatic research. 2010; 68(6):9.
26. Huijbregts KM, van Marwijk HW, de Jong FJ, Schreuders B, Beekman AT, van der Feltz-Cornelis CM. Adverse effects of multiple physical symptoms on the course of depressive and anxiety symptoms in primary care. Psychotherapy and psychosomatics. 2010; 79(6):389-91. doi: 10.1159/000320899 PMID: 20829652
27. Huijbregts KM, de Jong FJ, van Marwijk HW, Beekman AT, Ader HJ, van der Feltz-Cornelis CM. A high physical symptom count reduces the effectiveness of treatment for depression, independently of chronic medical conditions. Journal of psychosomatic research. 2013; 74(3):179-85. doi: 10.1016/j. jpsychores.2013.01.004 PMID: 23438706
28. Papakostas GI, Petersen TJ, Iosifescu DV, Summergrad P, Sklarsky BA, Alpert JE, et al. Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder. J Clin Psychiatry. 2004; 65(4):543-6. PMID: 15119918
29. Papakostas GI, Petersen T, Denninger J, Sonnawalla SB, Mahal Y, Alpert JE, et al. Somatic symptoms in treatment-resistant depression. Psychiatry Res. 2003; 118(1):39-45. PMID: 12759160
30. Papakostas GI, McGrath P, Stewart J, Charles D, Chen Y, Mischoulon D, et al. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder. Psychiatry Res. 2008; 161(1):116-20. doi: 10.1016/j.psychres.2008.02.011 PMID: 18755514
31. Keeley RD, Smith JL, Nutting PA, Miriam DL, Perry DW, Rost KM. Does a depression intervention result in improved outcomes for patients presenting with physical symptoms? J Gen Intern Med. 2004; 19(6):615-23. PMID: 15209599
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (Fifth ed.). Arlington, VA: American Psychiatric Publishing; 2013.
33. Rosendal M FP, Falkoe E, Schou Hansen H, Olesen F. Improving the Classification of Medically Unexplained Symptoms in Primary Care. Eur J Psychiat. 2007; 21:25-36.
34. Dimsdale JE. Somatic Symptom Disorders: a new approach in DSM-5. Die psychiatrie. 2013; 10:30-2.
35. Körber S FD, Steinbrecher N, HillerW. Classification characteristics of the Patient Health Questionnaire-15 for screening somatoformdisorders in a primary care setting. Journal of psychosomatic research. 2011; 71:142-7. doi: 10.1016/j.jpsychores.2011.01.006 PMID: 21843748
36. Burton C, McGorm K, Weller D, Sharpe M. Depression and anxiety in patients repeatedly referred to secondary care with medically unexplained symptoms: a case-control study. Psychol Med. 2011; 41(3):555-63. Epub 2011/01/29. doi: 10.1017/S0033291710001017 PMID: 21272387
37. Rosmalen J.G.M. TLM, de Jonge P. Empirical foundation for the diagnosis of somatization: implications for DSM-5. Psychol Med. 2010; 41:1133-42. doi: 10.1017/S0033291710001625 PMID: 20843407
38. de Graaf R, Ten Have M, van Dorsselaer S. The Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2): design and methods. Int J Methods Psychiatr Res. 2010; 19(3):125-41. doi: 10. 1002/mpr.317 PMID: 20641046
39. de Graaf R, ten Have M, van Gool C, van Dorsselaer S. Prevalence of mental disorders and trends from 1996 to 2009. Results from the Netherlands Mental Health Survey and Incidence Study-2. Soc Psychiatry Psychiatr Epidemiol. 2012; 47(2):203-13. doi: 10.1007/s00127-010-0334-8 PMID: 21197531
40. Haro JM, Arbabzadeh-Bouchez S, Brugha TS, de Girolamo G, Guyer ME, Jin R, et al. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHOWorld Mental Health surveys. Int J Methods Psychiatr Res. 2006; 15(4):167-80. PMID: 17266013
41. De Graaf R, van Dorsselaer S, Tuithof M, ten HaveM. Sociodemographic and psychiatric predictors of attrition in a prospective psychiatric epidemiological study among the general population. Result of the NetherlandsMental Health Survey and Incidence Study-2. Comprehensive Psychiatry. 2013; 54:1131-9. doi: 10.1016/j.comppsych.2013.05.012 PMID: 23810078
42. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Bmj. 1992; 305(6846):160-4. PMID: 1285753
43. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998; 51(11):1055-68. PMID: 9817123
44. Association AP. Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC2000.
45. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al. Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004(420:) :8-20. PMID: 15128383
46. De Graaf R, Ormel J, Ten Have M. Mental disorders and service use in The Netherlands. Results from the Eruoopean Study of the Epidemiology of Mental Disorders (ESEMeD). In: Kessler RC, Üstün TB, editors. The WHO World Mental Health Surveys Global Perspectives on the Epidemiology of Mental Disorders. New York: Cambridge University Press; 2008. p. 388-405.
47. de Graaf R, Ten Have M, Tuithof M, van Dorsselaer S. First-incidence of DSM-IV mood, anxiety and substance use disorders and its determinants: Results from the Netherlands Mental Health Survey and Incidence Study-2. J Affect Disord. 2013.
48. Andrews G, Peters L. The psychometric properties of the Composite International Diagnostic Interview. Soc Psychiatry Psychiatr Epidemiol. 1998; 33(2):80-8. PMID: 9503991
49. Wittchen HU. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res. 1994; 28(1):57-84. PMID: 8064641
50. CBS vademecum. "CBS vragenlijst chronische ziekten". 2005.
51. Baker MM, Stabile M., Deri C. What do self-reported, objective measures of health measure? NBER Working paper series. 2001.
52. Knight M, Stewart-Brown S, Fletcher L. Estimating health needs: the impact of a checklist of conditions and quality of life measurement on health information derived from community surveys. J Public Health Med. 2001; 23(3):179-86. PMID: 11585189
53. National Center for Health Statistics. Evaluation of national health interview survey diagnostic reporting. Series 2: Data evaluation and methods research1994.
54. Guthrie E, Thompson D. Abdominal pain and functional gastrointestinal disorders. Bmj. 2002; 325(7366):701-3. PMID: 12351366
55. Deyo RA, Rainville J, Kent DL. What can the history and physical examination tell us about low back pain? Jama. 1992; 268(6):760-5. PMID: 1386391
56. Skinner CJ, Holt D, Smith TMF. Analysis of Complex Surveys. Chichester: Willey; 1989.
57. Centraal Bureau voor de Statistiek. 'Gezondheid en zorg in cijfers'. Den Haag/Heerlen: 2012.
58. Hilderink PH, Collard R, Rosmalen JGM, Oude Voshaar RC. Prevalence of somatoform disorder and medically unexplained symptoms in old age polpulations in comparison with younger age groups: A systematic review. Ageing res rev. 2013; 12(1):151-6. doi: 10.1016/j.arr.2012.04.004 PMID: 22575906
59. van der Feltz-Cornelis CM, Swinkels JA, Blankenstein AH, Hoedeman R, Keuter EJ, stoornissen WSke. (The Dutch multidisciplinary guideline entitled 'Medically unexplained physical symptoms and somatoform disorder'). Ned Tijdschr Geneeskd. 2011; 155((18)A1244. Dutch.). PMID: 21429250
60. Walker EA, Keegan D, Gardner G, Sullivan M, Katon WJ, Bernstein D. Psychosocial Factors in Fibromyalgia Compared With Rheumatoid Arthritis: I. Psychiatric Diagnoses and Functional Disability. Psychosomatic medicine. 1997; 59(6):565-71. PMID: 9407573
61. Volker D, Vlasveld MC, Anema JR, Beekman AT, Hakkaart- van Roijen L, Brouwers EP, et al. Blended E-health module on return to work embedded in collaborative occupational health care for common mental disorders: design of a cluster randomized trial. Neuropsychiatric disease and treatment. 2013; 9:529-37. doi: 10.2147/NDT.S43969 PMID: 23637534
62. Van der Feltz-Cornelis CM, Hoedeman R, De Jong FJ, Meeuwissen JA, Drewes HW, Van der Laan NC, et al. Faster return to work after psychiatric consultation for sicklisted employees with common mental disorders compared to care as usual. A randomized clinical trial. Neuropsychiatric disease and treatment. 2010; 7(6):375-85.
63. van der Feltz-Cornelis CM, Meeuwissen JA, De Jong FJ, Hoedeman R, Elfeddali I. Randomised controlled trial of a psychiatric consultation model for treatment of common mental disorder in the occupational health setting. BMC Health Serv Res. 2007 27(7).